NCT06102460

Brief Summary

The goal of this clinical trial is to assess the effect of eating before bed (2 hours after dinner, 30mins before bed) and the effects this has on sleep and recovery measures in elite female athletes. Participants will be randomized to 4 possible groups in a double-blind randomized cross over design. Each group will ingest 40 grams of one of the following nutrients as a liquid shake for 3 consecutive nights:

  1. 1.Casein Protein
  2. 2.a-lactalbumin Protein
  3. 3.Carbohydrate
  4. 4.Placebo

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 13, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 26, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

January 23, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2025

Completed
Last Updated

March 25, 2025

Status Verified

March 1, 2025

Enrollment Period

1.1 years

First QC Date

October 13, 2023

Last Update Submit

March 20, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Sleep

    Sleep score determined by WHOOP 4.0 wearable device

    Data obtained from device 12 hours after ingestion of supplement

  • Recovery

    Recovery score determined by WHOOP 4.0 wearable device

    Data obtained from device 12 hours after ingestion of supplement

Secondary Outcomes (3)

  • Subjective sleep score

    Data obtained 1-2 hours after after subject awakes

  • Subjective recovery score

    Data obtained 1-2 hours after after subject awakes

  • Blood glucose control

    Continuous (24hours/day) during intervention days/nights

Study Arms (4)

Casein Protein

ACTIVE COMPARATOR

Each participant will consume a serving of casein protein mix.

Dietary Supplement: Casein protein

a-lactalbumin

ACTIVE COMPARATOR

Each participant will consume a serving of a-lactalbumin protein mix.

Dietary Supplement: a-lactalbumin protein

Carbohydrate

ACTIVE COMPARATOR

Each participant will consume a serving of carbohydrate mix.

Dietary Supplement: Carbohydrate

Placebo

PLACEBO COMPARATOR

Each participant will consume a serving of a placebo mix.

Dietary Supplement: Placebo

Interventions

Casein proteinDIETARY_SUPPLEMENT

40 grams of casein protein powder mixed with 8-10 fl. oz. of water.

Casein Protein
a-lactalbumin proteinDIETARY_SUPPLEMENT

40 grams of a-lactalbumin protein powder mixed with 8-10 fl. oz. of water.

a-lactalbumin
CarbohydrateDIETARY_SUPPLEMENT

40 grams of a carbohydrate powder mixed with 8-10 fl. oz. of water.

Carbohydrate
PlaceboDIETARY_SUPPLEMENT

Zero calorie, placebo powder mixed with 8-10 fl. oz. of water.

Placebo

Eligibility Criteria

Age18 Years - 25 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • NCAA Division I female athlete
  • Wearing WHOOP 4.0 device for \>3 months

You may not qualify if:

  • Musculoskeletal injuries limiting participation in regular team practice.
  • Cardiometabolic diseases limiting participation in regular team practice.
  • Pre-diagnosed sleep condition that would negatively affect sleep quality or quantity (sleep apnea, restless leg syndrome, night-feeding syndrome)
  • Allergy to any dietary supplement used in protocol - e.g., lactose intolerant.
  • Use of sleep aids such as but not limited to, melatonin.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Sports Sciences and Medicine - Florida State University

Tallahassee, Florida, 32303, United States

Location

MeSH Terms

Interventions

Carbohydrates

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Neither the participant or investigator will know what treatment has been given until un-blinding at the completion of the study.
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: All participants will complete all 4 interventions with at least a 1 week wash out period in between.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

October 13, 2023

First Posted

October 26, 2023

Study Start

January 23, 2024

Primary Completion

March 15, 2025

Study Completion

March 15, 2025

Last Updated

March 25, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations